LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $467,000 | +4.9% | 3,556 | +21.8% | 0.01% | 0.0% |
| Q1 2021 | $445,000 | +28.2% | 2,920 | -16.3% | 0.01% | +57.1% |
| Q4 2020 | $347,000 | +16.4% | 3,487 | +11.7% | 0.01% | 0.0% |
| Q3 2020 | $298,000 | -3.6% | 3,122 | +12.9% | 0.01% | 0.0% |
| Q2 2020 | $309,000 | +451.8% | 2,766 | +258.3% | 0.01% | +600.0% |
| Q1 2020 | $56,000 | -77.0% | 772 | -63.8% | 0.00% | -83.3% |
| Q2 2019 | $243,000 | -91.4% | 2,132 | -90.5% | 0.01% | -90.8% |
| Q1 2019 | $2,828,000 | +30.1% | 22,497 | +40.5% | 0.06% | +22.6% |
| Q4 2018 | $2,173,000 | -52.5% | 16,010 | -4.0% | 0.05% | -47.5% |
| Q3 2018 | $4,578,000 | +84.7% | 16,680 | +39.5% | 0.10% | +71.2% |
| Q2 2018 | $2,478,000 | +52.3% | 11,959 | +21.4% | 0.06% | +51.3% |
| Q1 2018 | $1,627,000 | -4.6% | 9,849 | -21.0% | 0.04% | 0.0% |
| Q4 2017 | $1,706,000 | +0.5% | 12,462 | 0.0% | 0.04% | 0.0% |
| Q3 2017 | $1,697,000 | +12.2% | 12,462 | 0.0% | 0.04% | +14.7% |
| Q2 2017 | $1,513,000 | +14.7% | 12,462 | 0.0% | 0.03% | +17.2% |
| Q1 2017 | $1,319,000 | +52.7% | 12,462 | +46.6% | 0.03% | +52.6% |
| Q4 2016 | $864,000 | +113.9% | 8,502 | +114.9% | 0.02% | +111.1% |
| Q3 2016 | $404,000 | -63.1% | 3,957 | -56.9% | 0.01% | -62.5% |
| Q2 2016 | $1,095,000 | -45.2% | 9,180 | -50.8% | 0.02% | -47.8% |
| Q1 2016 | $1,998,000 | -1.2% | 18,654 | 0.0% | 0.05% | -6.1% |
| Q4 2015 | $2,022,000 | +26.5% | 18,654 | 0.0% | 0.05% | +22.5% |
| Q3 2015 | $1,598,000 | +39.0% | 18,654 | +63.6% | 0.04% | +60.0% |
| Q2 2015 | $1,150,000 | +30.8% | 11,400 | 0.0% | 0.02% | +47.1% |
| Q1 2015 | $879,000 | +44.8% | 11,400 | 0.0% | 0.02% | +54.5% |
| Q4 2014 | $607,000 | +13.2% | 11,400 | 0.0% | 0.01% | +22.2% |
| Q3 2014 | $536,000 | +23.5% | 11,400 | +63.6% | 0.01% | +28.6% |
| Q2 2014 | $434,000 | – | 6,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |